Clinical characteristics of patients with Aspergillus species isolation from respiratory samples: Comparison of chronic pulmonary aspergillosis and colonization-Reference-Cited by-同舟云学术

Clinical characteristics of patients with Aspergillus species isolation from respiratory samples: Comparison of chronic pulmonary aspergillosis and colonization

Published:2016-03 Issue:2 Volume:54 Page:92-97
ISSN:2212-5345
Container-title:Respiratory Investigation
language:en
Short-container-title:Respiratory Investigation

Author:

Ohara Sayaka^ORCID,Tazawa Yoko,Tanai Chiharu,Tanaka Yoshiaki,Noda Hiromichi,Horiuchi Hajime,Usui Kazuhiro

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference13 articles.

1. The invasive and saprophytic syndromes due to Aspergillus spp;Hope;Med Mycol,2005

2. Guidelines for management of deep-seated mycoses 2014;Committee for Guideline for Management of Deep-seated Mycoses,2014

3. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review;Denning;Clin Infect Dis,2003

4. A case series of chronic necrotizing pulmonary aspergillosis and new proposal;Tashiro;Jpn J Infect Dis,2013

5. Treatment of aspergillosis: clinical practice guidelines of the Infectious Disease Society of America;Walsh;Clin Infect Dis,2008

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety analysis of oral isavuconazole therapy of invasive pulmonary aspergillosis;2024-06-25

2. Chronic Pulmonary Aspergillosis Caused by <i>Aspergillus tubingensis</i> Diagnosed by a Bronchoscopic Biopsy;Internal Medicine;2024-01-15

3. Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges;Therapeutic Advances in Infectious Disease;2024-01

4. Pathogenesis, Treatment Approaches and Challenges of Drug Resistance in Chronic Pulmonary Aspergillosis;Kansenshogaku Zasshi;2023-05-20

5. Nanotechnology-Based Approaches for Voriconazole Delivery Applied to Invasive Fungal Infections;Pharmaceutics;2023-01-12